E1bfe0c2-figure-01 (Image 1)
Diltiazem Hydrochloride Capsule, Extended Release
Product Images NDC 0228-2918
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Diltiazem Hydrochloride (NDC 0228-2918). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
E1bfe0c2-figure-02 (Image 2)
360mg 90s (Image 3)
Diltiazem Hydrochloride is a medication available in the form of extended-release capsules. Each capsule contains 360mg of Diltiazem Hydrochloride, USP, which is equivalent to 330.9 mg diitiazem. This medication is for once-a-day dosage and available in a pack of 90 capsules. It is recommended to store it at 25°C (77°F), with excursions permitted to 15° t0 30°C (59° to B6°F). This medication is manufactured by Teva Pharmaceuticals USA, Inc. and dispensed in light-resistant containers as per USP guidelines. The description also includes warnings, dosage recommendations, manufacturing details, and patent information.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
